According to a new review in American Journal of Transplantation, people who donate their kidney or part of their liver to help someone else may themselves encounter difficulty with life and health insurance, despite insurance companies saying otherwise.
“Insurance companies, when surveyed, stated they would insure living kidney donors, and would usually not charge higher premiums,” says review author Robert Yang, a research fellow in the Kidney Clinical Research Unit at the London Health Sciences Centre. “Despite that, 3-11 percent of donors still experienced insurance problems.”
Potential live donors worry about possible insurance problems in the future. As many as 14 percent of potential donors, from various countries with different social support and health care systems, expressed concern with their insurability if they were to donate an organ. Some research indicates that these concerns may lead a potential donor to reconsider donating.
Yang suggests that physicians should provide all information to patients before they make the important and life-altering decision to donate. “Even if donors are willing to accept the risks of non-insurability and/or higher insurance premiums, transplant professionals still have an ethical obligation to protect donor freedom of choice while ensuring that donors do not suffer unnecessary stress or financial penalty,” says Yang.
Source: Blackwell Publishing Ltd.
Related stories:
Updated guidelines for stem cell research released
The National Academies today released amended guidelines for research involving human embryonic stem cells, revising those that were issued in 2005 and updated in 2007. The Academies originally produced the guidelines to offer a common set of ethical standards for the responsible conduct of research using human stem cells, an area that, due to an absence of comprehensive federal funding, was lacking national standards. Since their initial release, the guidelines have served effectively as the basis for oversight of this research in the United States. In addition, a standing advisory committee -- a joint project between the Academies' National Research Council and Institute of Medicine -- was established to monitor and review scientific advances and determine any need for revisions.
Cancer 'cure' in mice to be tested in humans
Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.
Study confirms vCJD could be transmitted by blood transfusion
The findings underline the importance of precautions against vCJD transmission, such as the Government decision in 2004 to ban blood donations from anyone who had received a blood transfusion since 1980.
Victims of Britain's tainted blood scandal speak
(AP) -- Robert Mackie trembles with rage when he describes how he and his wife were kept in the dark about his HIV infection - and how doctors published his medical data in journals years before they gave him the devastating news.
Malaria Millennium Development Goal 'unlikely to be met'
The Millennium Development Goal (MDG) to halt and begin to reverse the incidence of malaria globally is unlikely to be met, according to Wellcome Trust Principal Research Fellow Professor Bob Snow. The statement comes in a report published today in the open access journal
PLoS Medicine.
3 sequencing companies join 1000 Genomes Project
Leaders of the 1000 Genomes Project announced today that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: 454 Life Sciences, a Roche company, Branford, Conn.; Applied Biosystems, an Applera Corp. business, Foster City, Calif.; and Illumina Inc., San Diego.
New Yorkers uneasy over organ-harvesting ambulance project
An ambulance rushes to the scene of an accident and the paramedics prepare to assist the victim. Behind them another ambulance rolls up, its paramedics ready to intervene if the patient dies.
Dallas area cornea shortages could benefit from national study
Surgeons and patients from UT Southwestern Medical Center and UT Southwestern Transplant Services Center joined in a landmark study showing that corneas from older donors are as successful for transplants after five years as is tissue from younger donors, allowing possible expansion of the donor pool.